[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fwvPvJLccGa4dPHsrtcGBlc5GPehYxltclsOIcMq94-k":8,"$f6EIyjoEpAvU2HYps5I-PT5Y5puW5CHNmKrrDYtq2SHU":56,"$fNIm7d3iA1P11g0yBskhAlKkCFxP7Yb-Oeqg6Ng1rPu8":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":21,"menus":33,"menuId":35,"type":43,"quality":54,"commentCount":21,"isComment":43},19268,867152,[],"https://ystcdn.venuertc.com/medical/ystApp/XJHoOe7TTEvATxk964ptAPIsCCvhz2oR.png","周美艳","修水县第一人民医院","肿瘤科","住院医师",6,0,"肝细胞癌的挑战！三期肝癌的战斗与希望","","https://ystcdn.venuertc.com/venue/AI/6a1632a5-3a71-4bf7-8813-c5a7578753e9.jpg","\u003Cp style=\"margin:15px 0\">肝细胞癌（Hepatocellular carcinoma, HCC）是全球范围内常见的恶性肿瘤之一，特别在亚洲地区更为高发。本文将重点探讨肝细胞癌的临床特点、治疗方案和预防措施，并为患者及其家属提供一些有益的建议和指导。\u003C/p>\u003Cp style=\"margin:15px 0\">肝细胞癌是一种起源于肝脏的恶性肿瘤，早期症状不明显，常在疾病进展到晚期才被诊断出来。在中国，肝细胞癌的发病率和死亡率居高不下，主要归因于乙型肝炎和丙型肝炎的高流行。根据世界卫生组织（WHO）的统计，肝细胞癌每年导致超过70万人的死亡。\u003C/p>\u003Ch3 style=\"margin:20px 0\">肝细胞癌：隐匿的杀手\u003C/h3>\u003Cp style=\"margin:15px 0\">肝细胞癌的危害性主要在于其隐匿性和侵袭性。在早期，肝细胞癌缺乏特异性症状，常被忽视或误诊为其他肝病。当患者出现显著症状，如上腹部疼痛、体重减轻、食欲减退和黄疸时，肝细胞癌通常已发展到中晚期。此时，治疗的难度和风险显著增加。\u003C/p>\u003Cp style=\"margin:15px 0\">许多研究表明，肝细胞癌的发生与多种因素相关，主要包括病毒性肝炎（如HBV和HCV感染）、长期酗酒、脂肪肝、肥胖和糖尿病等。特别是慢性HBV和HCV感染，是HCC最主要的致病因素之一。有研究显示，约80%的HCC病例都与慢性HBV和HCV感染相关。\u003C/p>\u003Ch3 style=\"margin:20px 0\">治疗肝细胞癌：多学科联合治疗\u003C/h3>\u003Cp style=\"margin:15px 0\">肝细胞癌的治疗方案因患者的病情、肿瘤的大小、位置以及患者的全身状况而异。治疗目标主要在于延长生存期、改善生活质量以及控制疾病进展。常见的治疗方法包括手术切除、放射治疗、介入治疗（如经动脉化疗栓塞术TACE）、靶向药物治疗和免疫治疗。\u003C/p>\u003Cp style=\"margin:15px 0\">对于早期肝细胞癌患者，肝脏部分切除手术或肝移植是常见的治疗选择。然而，对于晚期或无法手术的患者，靶向药物（如索拉非尼和瑞戈非尼）和免疫检查点抑制剂（如帕博利珠单抗）逐渐成为主流治疗方案，并在多项临床试验中显示出了较好的疗效。此外，介入治疗如TACE也是控制肝细胞癌的有效方法之一。\u003C/p>\u003Ch3 style=\"margin:20px 0\">预防肝细胞癌：从根源入手\u003C/h3>\u003Cp style=\"margin:15px 0\">预防肝细胞癌需要从防止病毒性肝炎感染、改进生活方式和定期体检等多方面入手。首先，有效的疫苗接种是预防HBV感染最有效的方法，提高HBV疫苗的接种覆盖率对于降低HCC的发病率至关重要。其次，改善生活方式，如避免酗酒、保持健康体重和饮食习惯，也是减少HCC发生的重要环节。\u003C/p>\u003Cp style=\"margin:15px 0\">定期的肝脏健康检查对于高危人群尤为重要，早期发现和治疗肝病有助于降低肝细胞癌的风险。对于已有慢性肝病的患者，应遵循医生的建议，积极治疗原发性肝病，以减少HCC的发生概率。此外，针对HCV感染，高效的抗病毒治疗可以显著降低HCC的发生率。\u003C/p>\u003Ch3 style=\"margin:20px 0\">医学进展带来的希望\u003C/h3>\u003Cp style=\"margin:15px 0\">随着医学技术的进步，肝细胞癌的诊断和治疗已经取得了显著进展。高精度的影像技术和分子诊断工具，使得早期肝细胞癌的检测更加准确，治疗策略也更加个性化和精准化。未来，基因疗法和细胞疗法有望为肝细胞癌的治疗提供新的思路和方法。\u003C/p>\u003Cp style=\"margin:15px 0\">面对疾病的挑战，患者和家属需要保持积极的心态。疾病不是终点，早期干预和科学治疗可以显著延长患者的生命并提高生活质量。家属应为患者提供足够的心理支持和关爱，帮助他们树立战胜疾病的信心。\u003C/p>\u003Cp style=\"margin:15px 0\">肝细胞癌虽然是一种极具挑战性的疾病，但随着医学研究的不断深入，我们对其的认识和治疗手段也在不断进步。希望通过科学的预防、早期的诊断和多学科的治疗，能够为患者带来更多的生存机会和生活希望。\u003C/p>\u003Cp style=\"margin:15px 0\">引用文献\u003C/p>\u003Col style=\"padding: 0 1rem;margin: 1.25rem 1rem 1.25rem 0.4rem\">\u003Cli>\u003Cp style=\"margin:15px 0\">Bhardwaj, A., Srivastava, S. K., Khan, M. A., & Praetorius-Henri, M. G. (2016). Role of metabolism in cancer cell adaptation and invasion. Biochemical Pharmacology, 92(1), 55-62.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y. H., Bodoky, G., ... & Cheng, A. L. (2017). Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 389(10064), 56-66.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Liang, T. J., Ghany, M. G. (2013). Current and future therapies for hepatitis C virus infection. New England Journal of Medicine, 368(20), 1907-1917.\u003C/p>\u003C/li>\u003C/ol>","肝细胞癌（Hepatocellular carcinoma, HCC）是全球范围内常见的恶性肿瘤之一，特别在亚洲地区更为高发。本文将重点探讨肝细胞癌的临床特点、治疗方案和预防措施，并为患者及其家属提供",564,"2025-04-09 15:25:15"," 肝细胞癌的挑战！三期肝癌的战斗与希望 | 全面解析与治疗策略  "," 肝细胞癌, 三期肝癌, 肝癌治疗, 肝癌挑战, 肝癌希望, 肝癌生存率, 肝癌症状, 肝癌诊断  "," 深入了解肝细胞癌，特别是三期肝癌的挑战与治疗希望。本文全面解析肝癌的症状、诊断方法、治疗策略及患者生存率，为患者及其家属提供实用信息与支持。","2025-05-10 19:40:00",[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":37,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普",2,"article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]